Position in PRGO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$18,093,425
+$11,975,857 QoQ
Shares Held
1,741,427
+205.7% QoQ
Ownership
1.25%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#21
of 334 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PRGO Over Time
Shares Held
Position Value (USD)
Derivatives in PRGO
reported options exposure · as of Sep 30, 2022CallValue
$2,763,650
CallShares
77,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $1,964,785,401 across 53 Drug Manufacturers - Specialty & Generic names. PRGO ranks #22 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,199,799 | $229,937,554 | |
| 2 | VTRS |
Viatris Inc
|
13,564,872 | $215,410,166 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
6,129,240 | $207,658,650 | |
| 4 | HIMS |
Hims & Hers Health, Inc.
|
5,173,865 | $179,377,897 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
631,892 | $106,499,075 | |
| 6 | ALKS |
Alkermes plc.
|
2,023,984 | $106,056,760 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
814,096 | $90,315,809 | |
| 8 | UTHR |
UNITED THERAPEUTICS Corp
|
165,979 | $89,932,399 |
All Filings in PRGO
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,093,425 | 1,741,427 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $6,117,568 | 569,606 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $4,318,748 | 310,255 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $12,844,154 | 576,747 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $24,536,334 | 918,276 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $32,519,893 | 1,159,768 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $13,158,017 | 511,786 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $21,445,751 | 817,604 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $14,369,577 | 559,563 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $5,955,986 | 185,026 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $10,303,230 | 320,175 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $5,918,193 | 185,233 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $8,558,318 | 252,086 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $9,310,631 | 259,566 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $48,199,133 | 1,413,879 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $50,677,887 | 1,421,141 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $2,763,650 | 77,500 | Call | Defined | 2024-05-14 | |
| 2022-06-30 | $89,232,781 | 2,199,477 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $4,158,425 | 102,500 | Call | Defined | 2024-05-14 | |
| 2022-03-31 | $118,149,536 | 3,074,409 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,556,000 | 40,000 | Call | Defined | 2022-02-17 | |
| 2021-12-31 | $100,140,540 | 2,574,307 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $42,006,037 | 887,514 | Shares | Defined | 2022-01-20 | |
| 2021-09-30 | $1,893,200 | 40,000 | Call | Defined | 2022-01-20 | |
| 2021-06-30 | $3,668,000 | 80,000 | Call | Defined | 2021-08-13 | |
| 2021-06-30 | $54,804,366 | 1,195,297 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $59,665,527 | 1,474,315 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $18,140,980 | 405,657 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $42,213,785 | 919,490 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $35,221,911 | 637,270 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $4,809,000 | 100,000 | Call | Defined | 2020-05-15 | |
| 2020-03-31 | $29,856,242 | 620,841 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||